Pharsight

Drugs that contain Nevirapine

1. Viramune Xr patents expiration

VIRAMUNE XR's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8460704 BOEHRINGER INGELHEIM Extended release formulation of nevirapine
Mar, 2029

(4 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Dosage Form(NDF) Mar 25, 2014
New Patient Population(NPP) Nov 08, 2015

Market Authorisation Date: 08 November, 2012

Treatment: Treatment of hiv-1 by once daily administration

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of VIRAMUNE XR before it's drug patent expiration?
More Information on Dosage

VIRAMUNE XR family patents

Family Patents